NPS has published new
information for health professionals
monitoring patients with metal-onmetal
total hip replacement
prostheses, which are under review
due to a higher than expected rate
of replacement surgery.
The information details how
patients should be assessed for
symptoms of potential toxicity.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 18 May 12
Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.
To sign up for a free subscription, click on the button at right.
